What will Alfasigma do with GSK?
Alfasigma, the Bologna-based pharmaceutical company owned by the Golinelli family, has acquired from GSK the exclusive worldwide rights for the development and commercialization of an innovative drug against itching caused by primary biliary cholangitis, through an agreement with a potential value of 690 million dollars. All the details.
